Aqilion focuses on diseases caused by chronic inflammation and dysfunctional immunological reactions.

AQILION explores novel scientific findings describing the biology behind the diseases and focus on developing new innovative treatments. Their mission is clear, the company identifies opportunities based on solid research resting on a firm biological foundation offering both clinical relevance and patient benefit.